<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03698604</url>
  </required_header>
  <id_info>
    <org_study_id>TLH-TAH-EN</org_study_id>
    <nct_id>NCT03698604</nct_id>
  </id_info>
  <brief_title>Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial Neoplasia</brief_title>
  <official_title>Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial Neoplasia; Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare operative time between total laparoscopy hysterectomy
      with bilateral salpingoophrectomy (TLH+BSO) versus total abdominal hysterectomy and bilateral
      salpingooophorectomy (TAH+BSO) in women with uterine neoplasia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research Questions:

      Is total laparoscopic hysterectomy associated with similar operative operative time as total
      abdominal hysterectomy and bilateral salpingoophrectomy in women with uterine neoplasia?

      Research Hypothesis:

      In women with uterine neoplasia TLH with BSO may be similar to TAH with BSO as regard
      operative time.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">August 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operative time</measure>
    <time_frame>From skin incision till closure of the vault &quot;up to 4 hours&quot;.</time_frame>
    <description>Operative time measured in minutes using stopwatch excluding time of concomitant surgical procedures.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>From skin incision start until skin suturing is finished &quot;up to 4 hours&quot;.</time_frame>
    <description>Intra operative blood loss will be estimated via:
Amount of blood in the suction bottle.
Estimation will be based on number of soaked gauzes and towels (soaked gauze = 20 ml blood; soaked towel = 150 ml; semi soaked towel = 75 ml).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood transfusion</measure>
    <time_frame>From admission to the hospital until the home discharge &quot;up to 1 week&quot;.</time_frame>
    <description>The need to blood transfusion to the patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>8 hours after the end of operation.</time_frame>
    <description>Assessment of pain intensity using Visual Analog Scale (VAS) which is one-dimensional measure of pain intensity.
It is a continuous scale comprised of a horizontal line, 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extreme. The scale is anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 100).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>From admission to the hospital until the home discharge &quot;up to 1 week&quot;.</time_frame>
    <description>Hospital stay duration in days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of operative complications</measure>
    <time_frame>During operation.</time_frame>
    <description>The need for laparotomy, and bowel or bladder or ureteric injury.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative complications</measure>
    <time_frame>Up to 1 week postoperative.</time_frame>
    <description>Morbidities e.g.:
Vaginal vault hematoma or pelvic hematoma or abscess.
Surgical site infection.
Urinary tract infection.
Need for post-operative blood transfusion.
Postoperative bowel or urinary tract complications.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Hysterectomy</condition>
  <condition>Laparoscopy</condition>
  <arm_group>
    <arm_group_label>Total Laparoscopic Hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The group that will undergo total laparoscopy hysterectomy with bilateral salpingoophrectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total Abdominal hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The group that will undergo total abdominal hysterectomy with bilateral salpingoophrectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysterectomy</intervention_name>
    <description>Total Laparoscopic Hysterectomy Total Abdominal hysterectomy</description>
    <arm_group_label>Total Abdominal hysterectomy</arm_group_label>
    <arm_group_label>Total Laparoscopic Hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The presence of perimenopausal bleeding

          -  Early stage endometrial carcinoma.

          -  Endometrial hyperplasia with/without atypia.

        Exclusion Criteria:

          -  Obese patients i.e., BMI&lt; 29 k.g/m2.

          -  Patients unfit for laparoscopy as patients with cardio-pulmonary compromise.

          -  Presence of adnexal mass.

          -  End stage endometrial carcinoma stage 3 &amp; 4.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Walid E Mohammed, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams Maternity Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mortada E Ahmed, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams Maternity Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ain Shams Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>September 26, 2018</study_first_submitted>
  <study_first_submitted_qc>October 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>October 4, 2018</last_update_submitted>
  <last_update_submitted_qc>October 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Rania Gamal Anwar Elskaan</investigator_full_name>
    <investigator_title>Assistant Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>November 10, 2018</submitted>
    <returned>March 7, 2019</returned>
    <submitted>March 10, 2019</submitted>
    <returned>June 7, 2019</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

